We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+23.2%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$75M
Cap. Flow
+$46.3M
Cap. Flow %
14.89%
Top 10 Hldgs %
18.62%
Holding
1,633
New
628
Increased
240
Reduced
242
Closed
312

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.5M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$3.75M
3
UNH icon
UnitedHealth
UNH
+$3.2M
4
FCRS.U
FutureCrest Acquisition Corp Units
FCRS.U
+$2.72M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.71M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$5.26M
2
VOD icon
Vodafone
VOD
+$5.12M
3
ERIC icon
Ericsson
ERIC
+$4.88M
4
JNPR
Juniper Networks
JNPR
+$4.21M
5
CCIR
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Healthcare 12.39%
3 Financials 11.37%
4 Consumer Discretionary 7.84%
5 Industrials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVG icon
501
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.69B
$46K 0.01%
3,800
– –
PTY icon
502
PIMCO Corporate & Income Opportunity Fund
PTY
$2.49B
$46K 0.01%
3,200
– –
DAR icon
503
Darling Ingredients
DAR
$10.4B
$45K 0.01%
1,471
+135
+10% +$4.51K
EVLV icon
504
Evolv Technologies
EVLV
$1.04B
$45K 0.01%
6,000
-2,000
-25% -$14.6K
HCAT icon
505
Health Catalyst
HCAT
$132M
$45K 0.01%
+16,000
New +$54.8K
PRMB
506
Primo Brands
PRMB
$8.97B
$45K 0.01%
2,047
+1,378
+206% +$35.7K
ALEC icon
507
Alector
ALEC
$228M
$44K 0.01%
15,000
-5,000
-25% -$11K
ALIT icon
508
Alight
ALIT
$394M
$44K 0.01%
682
-1,858
-73% -$164K
BOX icon
509
Box
BOX
$4.66B
$44K 0.01%
+1,365
New +$44.2K
DENN
510
DELISTED
Denny's
DENN
$44K 0.01%
8,549
+4,549
+114% +$20.2K
KKR icon
511
KKR & Co
KKR
$103B
$44K 0.01%
+342
New +$48.5K
NLOP
512
Net Lease Office Properties
NLOP
$173M
$44K 0.01%
+1,500
New +$47.1K
QGEN icon
513
Qiagen
QGEN
$8.93B
$44K 0.01%
+1,000
New +$47.9K
TASK icon
514
TaskUs
TASK
$667M
$44K 0.01%
+2,500
New +$43.2K
XLP icon
515
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$44K 0.01%
+564
New +$45.6K
FOLD
516
DELISTED
Amicus Therapeutics
FOLD
$43K 0.01%
+5,460
New +$38.9K
MSGS icon
517
Madison Square Garden
MSGS
$9.94B
$43K 0.01%
191
-343
-64% -$70.3K
EOD
518
Allspring Global Dividend Opportunity Fund
EOD
$289M
$42K 0.01%
7,500
– –
KVUE icon
519
CALL
Kenvue
KVUE
$36.9B
$42K 0.01%
2,592
+1,264
+95% +$25.8K
MDB icon
520
MongoDB
MDB
$38B
$42K 0.01%
136
-799
-85% -$205K
SBET icon
521
Sharplink Inc
SBET
$1.37B
$42K 0.01%
+2,484
New +$48.8K
RZLV
522
Rezolve AI
RZLV
$1.06B
$42K 0.01%
+8,500
New +$33.5K
AMKR icon
523
Amkor Technology
AMKR
$14.3B
$41K 0.01%
1,472
+670
+84% +$16.1K
CMA
524
DELISTED
Comerica
CMA
$41K 0.01%
600
– –
DIAX
525
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
$41K 0.01%
2,800
– –
19 20
21
22 23

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

FNY Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, FNY Investment Advisers held 1,633 positions worth $311M, up 32% from $236M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

FNY Investment Advisers deployed $46.3M of net new capital in Q3 2025, opening 628 new positions and adding to 240 existing holdings. Its largest new stake was Verona Pharma: 148,120 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ramaco Resources Class A, an estimated $3.39M trimmed.

  • FNY Investment Advisers's largest Q3 2025 buy was Verona Pharma: 148,120 shares worth $15.8M.
  • FNY Investment Advisers added most to UnitedHealth in Q3 2025, an estimated $3.2M increase.
  • FNY Investment Advisers's biggest Q3 2025 reduction was Ramaco Resources Class A, cutting an estimated $3.39M.
  • FNY Investment Advisers fully exited Blueprint Medicines in Q3 2025, selling an estimated $5.26M.
  • FNY Investment Advisers's ten largest holdings make up 19% of its $311M portfolio in Q3 2025.
  • FNY Investment Advisers opened 628 new positions and closed 312 in Q3 2025.
  • FNY Investment Advisers's portfolio value rose 32% quarter-over-quarter to $311M.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.